|
|
中医药治疗胃癌微环境的研究进展
|
Abstract:
肿瘤微环境的改变导致了细胞基因突变，是肿瘤发生的重要原因，针对肿瘤微环境进行干预的治疗是近年来肿瘤界最受关注的研究领域之一。中医学独特的整体观念与肿瘤微环境的概念有着相通之处，中医药改善胃癌肿瘤微环境疗效确切，其理论基础及现代机制已有诸多探索研究。因此，笔者对近年来中医药有关胃癌肿瘤微环境的文章进行搜集，对认识及干预胃癌肿瘤微环境的研究现状进行了归纳分析，以求为今后中医药干预胃癌肿瘤微环境的研究提供新的参考与路径。
The change of tumor microenvironment leads to cell gene mutation, which is an important cause of tumor occurrence, and the intervention of tumor microenvironment is one of the most popular re-search fields in the tumor field in recent years. The unique overall concept of traditional Chinese medicine has similarities with the concept of tumor microenvironment, and traditional Chinese medicine has a definite curative effect on improving gastric cancer tumor microenvironment, and its theoretical basis and modern mechanism have been explored and studied. Therefore, the author collected the articles about gastric cancer tumor microenvironment in recent years, and summa-rized and analyzed the research status of understanding and intervention of gastric cancer tumor microenvironment, so as to provide new reference and path for the future research of traditional Chinese medicine intervention of gastric cancer tumor microenvironment.
| [1] | 王润兮, 杨舒涵, 房立源, 等. 中医药“以平为期”调整肿瘤免疫微环境稳态[J]. 肿瘤防治研究, 2023, 50(11): 1114-1120. |
| [2] | 王新苗. 扶正解毒方调控衰老CAFs改善免疫抑制及化疗抵抗机制研究[D]: [博士学位论文]. 北京: 中国中医科学院, 2023. |
| [3] | Boedtkjer, E. and Pedersen, S.F. (2020) The Acidic Tumor Microenvironment as a Driver of Cancer. Annual Review of Physiology, 82, 103-126. https://doi.org/10.1146/annurev-physiol-021119-034627 |
| [4] | Eskuri, M., Kemi, N. and Kauppila, J.H. (2021) Monocarboxylate Transporters 1 and 4 and MTCO1 in Gastric Cancer. Cancers, 13, Article 2142. https://doi.org/10.3390/cancers13092142 |
| [5] | 汪婷婷, 何永文. 单羧酸转运蛋白家族介导乳酸转运在肿瘤发生发展中的作用[J]. 中国肿瘤临床, 2020, 47(7): 354-358. |
| [6] | Cao, Y., Liu, Y., Dong, Z., et al. (2018) Monocar-boxylate Transporters MCT1 and MCT4 Are Independent Prognostic Biomarkers for the Survival of Patients with Clear Cell Renal Cell Carcinoma and Those Receiving Therapy Targeting Angiogenesis. Urologic Oncology, 36, 311.e15-311.e25. https://doi.org/10.1016/j.urolonc.2018.03.014 |
| [7] | 喻俊榕, 郝彦伟, 程敬, 等. 基于MCT4/CD147探讨四君子汤加减改善酸性微环境逆转胃癌前病变的效应机制[J]. 中国实验方剂学杂志, 2021, 27(6): 30-36. |
| [8] | Gao, S., Chen, M., Wei, W., et al. (2019) Crosstalk of mTOR/PKM2 and STAT3/c-Myc Signaling Pathways Regulate the Energy Metabolism and Acidic Microenvironment of Gastric Cancer. Journal of Cellular Bio-chemistry, 120, 1193-1202.
https://doi.org/10.1002/jcb.26915 |
| [9] | Gao, Y., Qi, W., Liu, S., et al. (2019) Acid-Induced Autophagy Protects Human Gastric Cancer Cells from Apoptosis by Activating Erk1/2 Pathway. Translational Cancer Research, 8, 1560-1570. https://doi.org/10.21037/tcr.2019.07.42 |
| [10] | Hong, R. and Han, S.I. (2018) Extracellular Acidity En-hances Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)-Mediated Apoptosis via DR5 in Gastric Cancer Cells. The Korean Journal of Physiology & Pharmacology, 22, 513-523. https://doi.org/10.4196/kjpp.2018.22.5.513 |
| [11] | Lim, S.C., Kee, K.H., Lee, M.J., Hong, R. and Han, S.I. (2020) Extracellular Acidity-Induced Expression of Kallikrein-Related Peptidases 7 and 8 Is Involved in Increased Invasiveness of Gastric Cancer Cells. Oncology Reports, 43, 1705-1713. https://doi.org/10.3892/or.2020.7529 |
| [12] | 吴秋雪, 孙梦瑶, 许博, 等. 左金丸醇提物抑制人胃癌SGC-7901细胞糖酵解的作用机制[J]. 中草药, 2021, 52(1): 145-151. |
| [13] | 李锡丁, 周永平, 李旻昊, 等. 川楝素对胃癌细胞糖酵解效应的影响及相关机制[J]. 江苏大学学报(医学版), 2021, 31(6): 501-505, 510. |
| [14] | 邵久针. 基于CAFs通路介导的肿瘤微环境探讨健脾化痰方干预胃癌转移的作用机制[D]: [硕士学位论文]. 南京: 南京中医药大学, 2020. |
| [15] | Chen, Y., Mcandrews, K.M. and Kalluri, R. (2021) Clinical and Therapeutic Relevance of Cancer-Associated Fibroblasts. Nature Reviews Clinical Oncology, 18, 792-804. https://doi.org/10.1038/s41571-021-00546-5 |
| [16] | 魏金五, 李桂香. 肿瘤相关成纤维细胞在胃癌中的作用及研究进展[J]. 兰州大学学报(医学版), 2022, 48(4): 66-71. |
| [17] | Yasuda, T., Koiwa, M., Yonemura, A., et al. (2021) Inflammation-Driven Senescence-Associated Secretory Phenotype in Cancer-Associated Fibroblasts Enhances Peritoneal Dissemination. Cell Reports, 34, Article ID: 108779.
https://doi.org/10.1016/j.celrep.2021.108779 |
| [18] | Zhang, T., Li, X., He, Y., et al. (2022) Cancer-Associated Fibro-blasts-Derived HAPLN1 Promotes Tumour Invasion through Extracellular Matrix Remodeling in Gastric Cancer. Gas-tric Cancer, 25, 346-359.
https://doi.org/10.1007/s10120-021-01259-5 |
| [19] | 郝钦, 杨永雁, 韩雅玲, 等. 漏芦逆转胃癌相关成纤维细胞促癌作用的研究[J]. 中药药理与临床, 2017, 33(1): 119-123. |
| [20] | 谢贵萍. 黄芪四君子汤增强进展期胃癌术前辅助化疗敏感性及相关机制的初步研究[D]: [硕士学位论文]. 南京: 南京中医药大学, 2021. |
| [21] | Wang, Z., Ma, D., Zhu, Z., et al. (2017) Astragaloside IV Inhibits Pathological Functions of Gastric Cancer-Associated Fibroblasts. World Journal of Gastroenterology, 23, 8512-8525. https://doi.org/10.3748/wjg.v23.i48.8512 |
| [22] | Wang, Z., Ma, D., Wang, L., et al. (2019) Paeoniflorin Inhibits Migration- and Invasion-Promoting Capacities of Gastric Cancer Associated Fibroblasts. Chinese Journal of Integrative Medicine, 25, 837-844.
https://doi.org/10.1007/s11655-018-2985-3 |
| [23] | Zhang, Q., Bi, J., Zheng, X., et al. (2018) Blockade of the Checkpoint Receptor TIGIT Prevents NK Cell Exhaustion and Elicits Potent Anti-Tumor Immunity. Nature Immunology, 19, 723-732.
https://doi.org/10.1038/s41590-018-0132-0 |
| [24] | Kim, J.Y., Kim, W.G., Kwon, C.H. and Park, D.Y. (2019) Dif-ferences in Immune Contextures among Different Molecular Subtypes of Gastric Cancer and Their Prognostic Impact. Gastric Cancer, 22, 1164-1175.
https://doi.org/10.1007/s10120-019-00974-4 |
| [25] | 严展鹏, 徐婷婷, 朱方石. 调节性T细胞促进胃癌发生的研究进展[J]. 细胞与分子免疫学杂志, 2016, 32(8): 1140-1143. |
| [26] | Fang, F., Zhang, T., Li, Q., et al. (2022) The Tu-mor Immune-Microenvironment in Gastric Cancer. Tumori Journal, 108, 541-551. https://doi.org/10.1177/03008916211070051 |
| [27] | Becerril-Rico, J., Alvarado-Ortiz, E., Toledo-Guzmán, M.E., et al. (2021) The Cross talk between Gastric Cancer Stem Cells and the Immune Microenvironment: A Tumor-Promoting Factor. Stem Cell Research & Therapy, 12, Article No. 498. https://doi.org/10.1186/s13287-021-02562-9 |
| [28] | Fu, L., Bu, L., Yasuda, T., et al. (2020) Gastric Cancer Stem Cells: Current Insights into the Immune Microenvironment and Therapeutic Targets. Biomedicines, 8, Article 7. https://doi.org/10.3390/biomedicines8010007 |
| [29] | 吴坚, 陈彦臻, 张星星, 等. 益气健脾化瘀方协同5-FU对胃癌的抑制作用及机制[J]. 中国实验方剂学杂志, 2020, 26(7): 65-72. |
| [30] | 陈昳菲, 任牡丹, 卢新兰, 等. 青藤碱调节胃癌细胞诱发的巨噬细胞M2极化的机制[J]. 西安交通大学学报(医学版), 2022, 43(3): 436-443. |
| [31] | Yuan, M., Zou, X., Liu, S., et al. (2020) Modified Jian-pi-yang-zheng Decoction Inhibits Gastric Cancer Progression via the Macrophage Immune Checkpoint PI3Kγ. Biomedicine & Pharma-cotherapy, 129, Article ID: 110440.
https://doi.org/10.1016/j.biopha.2020.110440 |
| [32] | 徐静, 黄艳, 吴璐一, 等. Tim-3与胃癌肿瘤相关巨噬细胞的关系及艾灸调节作用的研究进展[J]. 上海针灸杂志, 2021, 40(2): 226-233. |
| [33] | Zhao, W., Liu, M., Zhang, M., et al. (2021) Effects of Inflammation on the Immune Microenvironment in Gastric Cancer. Frontiers in Oncology, 11, Article 2810. https://doi.org/10.3389/fonc.2021.690298 |
| [34] | 程叶, 蒯晴叶, 张艳, 等. TAM在肿瘤免疫治疗中的研究进展[J/OL]. 肿瘤: 1-11.
http://kns.cnki.net/kcms/detail/31.1372.R.20230901.0848.002.html, 2023-12-24. |
| [35] | 石枫, 陈希琦, 许振国, 等. 肿瘤相关巨噬细胞在胃癌中的作用研究进展[J]. 中国中西医结合外科杂志, 2022, 28(5): 726-729. |
| [36] | 翟文萍, 董超男, 王雪野. 胃癌相关炎症因子研究进展[J]. 医学综述, 2020, 26(7): 1314-1318, 1324. |
| [37] | 牛世伟, 龚红霞, 付晓燕, 等. IL-17及其介导的信号通路在胃癌中的研究进展[J]. 医学研究生学报, 2022, 35(6): 660-663. |
| [38] | 伍丹丹, 董卫国. TNF-α在胃癌发生发展中的作用及治疗研究进展[J]. 疑难病杂志, 2018, 17(4): 428-432. |
| [39] | 张子杭, 成元华. 转化生长因子-β通路对胃癌细胞在裸鼠体内增殖、侵袭及slug蛋白和上皮钙黏素基因表达的影响[J]. 安徽医药, 2023, 27(9): 1804-1808. |
| [40] | Park, J., Seo, J., Jeon, H., et al. (2020) Lentivirus-Mediated VEGF Knockdown Suppresses Gastric Cancer Cell Proliferation and Tumor Growth in Vitro and in Vivo. OncoTargets and Therapy, 13, 1331-1341.
https://doi.org/10.2147/OTT.S234344 |
| [41] | Wu, Z., Pan, X., Deng, C., et al. (2022) Mechanism of Herb Pairs Astragalus mongholicus and Curcuma phaeocaulis Valeton in Treating Gastric Carcinoma: A Network Pharmacology Combines with Differential Analysis and Molecular Docking. Evidence-Based Complementary and Alternative Medicine, 2022, Article ID: 8361431.
https://doi.org/10.1155/2022/8361431 |
| [42] | 王载川. 扶正清毒方调控G-MDSCs延缓胃癌进展的机制研究[D]: [硕士学位论文]. 扬州: 扬州大学, 2022. |
| [43] | 李绍智, 练维生. 连翘苷调控LINC00342影响胃癌细胞增殖、迁移和侵袭及炎症因子表达的实验研究[J]. 世界华人消化杂志, 2022, 30(4): 182-190. |
| [44] | Sebestyén, A., Kopper, L., Dankó, T. and Tímár, J. (2021) Hypoxia Signaling in Cancer: From Basics to Clinical Practice. Pathology & Oncology Research, 27, Article ID: 1609802. https://doi.org/10.3389/pore.2021.1609802 |
| [45] | Jung, J., Zhang, Y., Celiku, O., et al. (2019) Mitochondrial NIX Promotes Tumor Survival in the Hypoxic Niche of Glioblastoma Mitochondrial NIX Maintains Hypoxic Niche of Glioblastoma. Cancer Research, 79, 5218-5232.
https://doi.org/10.1158/0008-5472.CAN-19-0198 |
| [46] | Li, H., Jia, Y. and Wang, Y. (2019) Targeting HIF-1α Sig-naling Pathway for Gastric Cancer Treatment. Die Pharmazie: An International Journal of Pharmaceutical Sciences, 74, 3-7. |
| [47] | 赵乙锾, 徐洪雨. 缺氧诱导因子在胃癌中的作用及机制研究进展[J]. 现代消化及介入诊疗, 2021, 26(6): 782-785. |
| [48] | 金烨, 颜海豪, 代璐, 等. 缺氧诱导因子-1在胃癌中的研究进展[J]. 中国临床研究, 2021, 34(3): 405-408. |
| [49] | Li, M., Li, G., Yang, X., et al. (2022) HIF in Gastric Cancer: Regulation and Therapeutic Target. Mole-cules, 27, Article 4893. https://doi.org/10.3390/molecules27154893 |
| [50] | 杜雄, 李延新, 段小瑞, 等. 缺氧诱导的间充质干细胞外泌体对胃癌细胞生长和转移的影响及机制[J]. 国际检验医学杂志, 2021, 42(22): 2724-2728, 2734. |
| [51] | 刘伟, 胡永波, 白少华, 等. 缺氧胃癌癌细胞衍生的外泌体转移miR-143-5p促进胃癌侵袭、转移[J]. 胃肠病学和肝病学杂志, 2021, 30(12): 1331-1338. |
| [52] | 龚红霞. 基于中医药化学生物信息学探讨归芪白术方通过VEGFR-2和c-Met对胃癌生长和转移的影响[D]: [硕士学位论文]. 兰州: 甘肃中医药大学, 2022. |
| [53] | Guan, J., Cao, Z., Guan, B., et al. (2021) Effect of Babao Dan on Angiogenesis of Gastric Cancer in Vitro by Regulating VEGFA/VEGFR2 Signaling Pathway. Translational Cancer Research, 10, 953-965.
https://doi.org/10.21037/tcr-20-2559 |
| [54] | 王兴龙. 健脾益气方剂含药血清对胃癌细胞生长及血管新生的影响[J]. 海南医学院学报, 2019, 25(10): 750-753, 757. |
